{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:19:39Z","timestamp":1786580379577,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.amjms.2016.05.032","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T20:37:37Z","timestamp":1464986257000},"page":"239-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus"],"prefix":"10.1016","volume":"352","author":[{"given":"Johnathon Drake","family":"Bishop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"DeShields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Troy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjms.2016.05.032_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.280.1.78","article-title":"Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel","volume":"280","author":"Carpenter","year":"1998","journal-title":"J Am Med Assoc"},{"issue":"9327","key":"10.1016\/j.amjms.2016.05.032_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.amjms.2016.05.032_bib3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.amjms.2016.05.032_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1086\/510746","article-title":"CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression","volume":"44","author":"Moore","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.amjms.2016.05.032_bib5","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1001\/archinte.163.18.2187","article-title":"CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study","volume":"163","author":"Kaufmann","year":"2003","journal-title":"Arch Intern Med"},{"issue":"16","key":"10.1016\/j.amjms.2016.05.032_bib6","first-page":"2469","article-title":"Virologic and immunologic response to HAART, by age and regimen class","volume":"24","author":"Althoff","year":"2010","journal-title":"Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.amjms.2016.05.032_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00126334-200406010-00007","article-title":"Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count","volume":"36","author":"Garc\u00eda","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amjms.2016.05.032_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1186\/s13104-015-1406-3","article-title":"Pattern and predictors of immunologic recovery in HIV infected patients","volume":"8","author":"Kwofie","year":"2015","journal-title":"BMC Res Notes"},{"issue":"2","key":"10.1016\/j.amjms.2016.05.032_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00042560-200106010-00012","article-title":"Increase and plateau of CD4 T-cell counts in the 3(1\/2) years after initiation of potent antiretroviral therapy","volume":"27","author":"Tarwater","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4 suppl 3","key":"10.1016\/j.amjms.2016.05.032_bib10","doi-asserted-by":"crossref","first-page":"19481","DOI":"10.7448\/IAS.17.4.19481","article-title":"CD4+ cell count recovery in na\u00efve patients initiating cART, who achieved and maintained plasma HIV-RNA suppression","volume":"17","author":"Costagliola","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"10.1016\/j.amjms.2016.05.032_bib11","doi-asserted-by":"crossref","first-page":"ofv079","DOI":"10.1093\/ofid\/ofv079","article-title":"CD4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in Latin America and the Caribbean","volume":"2","author":"Luz","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.amjms.2016.05.032_bib12","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1089\/apc.2015.0040","article-title":"Differences in response to antiretroviral therapy by sex and hepatitis C infection status","volume":"29","author":"Marcus","year":"2015","journal-title":"AIDS Patient Care STDS"},{"issue":"3","key":"10.1016\/j.amjms.2016.05.032_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/431484","article-title":"Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells\/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy","volume":"41","author":"Kaufmann","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.amjms.2016.05.032_bib14","first-page":"835","article-title":"Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART","volume":"21","author":"Collazos","year":"2007","journal-title":"Acquir Immune Defic Syndr"},{"key":"10.1016\/j.amjms.2016.05.032_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-6405-4-11","article-title":"Predictors of disease progression in HIV infection: a review","volume":"4","author":"Langford","year":"2007","journal-title":"AIDS Res Ther"},{"key":"10.1016\/j.amjms.2016.05.032_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/hiv.12259","article-title":"Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010","author":"Koethe","year":"2015","journal-title":"HIV Med"},{"issue":"2","key":"10.1016\/j.amjms.2016.05.032_bib17","first-page":"193","article-title":"Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults","volume":"29","author":"Marzolini","year":"2015","journal-title":"Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1016\/j.amjms.2016.05.032_bib18","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/592113","article-title":"CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy","volume":"47","author":"Khanna","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2016.05.032_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/aid.2009.0001","article-title":"Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population","volume":"26","author":"Zaragoza-Macias","year":"2010","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962916300246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962916300246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:22:07Z","timestamp":1617236527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962916300246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0002962916300246"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2016.05.032","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2016.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Southern Society for Clinical Investigation. Published by All rights reserved.","name":"copyright","label":"Copyright"}]}}